+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Statins Market by Product Type, Dosage Form, Distribution Channel, End User - Global Forecast to 2030- Product Image
Statins Market by Product Type, Dosage Form, Distribution Channel, End User - Global Forecast to 2030- Product Image
Sale

Statins Market by Product Type, Dosage Form, Distribution Channel, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082885
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The statins market is evolving as industry leaders, payers, and regulators adapt to shifting demand and broader cardiovascular healthcare dynamics. Executives across the pharmaceutical and healthcare value chain must respond swiftly to new policy pressures, emerging patient needs, and efficiency imperatives. In an era of rapid change, informed decisions are critical to navigating this complex therapeutic landscape.

Market Snapshot: Statins Market Trends and Growth

The Statins Market grew from USD 33.30 billion in 2024 to USD 35.35 billion in 2025. It is expected to continue growing at a CAGR of 5.95%, reaching USD 47.11 billion by 2030. The sector reflects stable expansion, with demand being driven by ongoing incidence of cardiovascular disease, evolving clinical guidelines, and increasing patient populations in both developed and emerging regions. Competition between branded and generic drugs, as well as the introduction of innovative therapies and combination products, is influencing market direction.

Scope & Segmentation

  • Product Types: Branded statins (including Atorvastatin, Rosuvastatin, Simvastatin) and generic formulations.
  • Dosage Forms: Available as capsules and tablets, with new formulations addressing pharmacokinetic profiles and patient adherence.
  • Distribution Channels: Access provided through hospital pharmacies, online pharmacies, and retail pharmacies to support different buyer and patient profiles.
  • End Users: Deployed across clinics, homecare facilities, hospitals, and specialty centers to reach varied care settings and patient populations.
  • Geographic Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (spanning UK, Germany, France, Russia, Italy, Spain, UAE, and several others); Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, and more).
  • Key Companies: Pfizer Inc., AstraZeneca PLC, Merck & Co., Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Viatris Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Limited, Apotex Inc.

Key Takeaways for Decision-Makers

  • Statin therapeutics are adapting to digital health integration, with technologies supporting adherence monitoring and personalized dosing.
  • Value-based healthcare models are increasing pressure on manufacturers to demonstrate outcomes beyond cholesterol reduction, such as comprehensive cardiovascular risk mitigation.
  • The loss of exclusivity on key brands has prompted significant generic competition, putting pressure on both pricing models and profit margins, and highlighting the need for portfolio differentiation.
  • Regional adoption varies considerably, with advanced regulatory and reimbursement structures accelerating product availability in developed markets, while tiered pricing and patient assistance programs drive uptake in emerging economies.
  • Strategic collaborations, including those with CDMOs and digital health partners, have become central to launching novel fixed-dose combinations and scaling new solutions quickly.

Tariff Impact on Statin Manufacturing Costs

Recent cumulative tariffs on imported pharmaceutical ingredients in 2025 have added complexity and cost to statin production, pushing manufacturers to re-evaluate supply strategies. Localization of API production and expanded partnerships with domestic producers and contract manufacturers are increasing in importance as a means to mitigate cost volatility. In some markets, these factors are driving new discussions on copay models and outcomes-based reimbursement approaches for end-users.

Methodology & Data Sources

This report is grounded in rigorous secondary data review, expert interviews, and multilayered validation. Quantitative and qualitative insights were cross-referenced against company reports, regulatory filings, and in-depth interviews with senior executives, supply chain specialists, and clinical experts. Analytical frameworks such as SWOT and Porter’s Five Forces were applied, and findings were peer-reviewed to ensure reliability and transparency.

Why This Report Matters

  • Enables informed, agile decision-making for investments, portfolio management, and risk mitigation in the statin therapeutics space.
  • Delivers strategic clarity on evolving market drivers, including digital innovation, regulatory shifts, and cost-management imperatives.
  • Equips executives to anticipate the impact of supply chain changes and regional dynamics on product access and commercialization strategies.

Conclusion

The statins market is navigating transformation in technology, policy, and partnership models. Senior leaders who act on data-driven insights and respond to evolving market dynamics will position their organizations to capture new growth opportunities and optimize cardiovascular outcomes globally.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Statins Market, by Product Type
8.1. Introduction
8.2. Branded
8.2.1. Atorvastatin
8.2.2. Rosuvastatin
8.2.3. Simvastatin
8.3. Generic
9. Statins Market, by Dosage Form
9.1. Introduction
9.2. Capsule
9.3. Tablet
10. Statins Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Statins Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Homecare Facilities
11.4. Hospitals
11.5. Specialty Centers
12. Americas Statins Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Statins Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Statins Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Pfizer Inc.
15.3.2. AstraZeneca PLC
15.3.3. Merck & Co., Inc.
15.3.4. Novartis AG
15.3.5. Teva Pharmaceutical Industries Ltd.
15.3.6. Sandoz International GmbH
15.3.7. Viatris Inc.
15.3.8. Sun Pharmaceutical Industries Ltd.
15.3.9. Dr. Reddy's Laboratories Limited
15.3.10. Apotex Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. STATINS MARKET MULTI-CURRENCY
FIGURE 2. STATINS MARKET MULTI-LANGUAGE
FIGURE 3. STATINS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL STATINS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL STATINS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL STATINS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL STATINS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL STATINS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL STATINS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL STATINS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL STATINS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL STATINS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS STATINS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS STATINS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES STATINS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES STATINS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA STATINS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA STATINS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC STATINS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC STATINS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. STATINS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. STATINS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. STATINS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL STATINS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL STATINS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL STATINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL STATINS MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL STATINS MARKET SIZE, BY ATORVASTATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL STATINS MARKET SIZE, BY ROSUVASTATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL STATINS MARKET SIZE, BY SIMVASTATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL STATINS MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL STATINS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL STATINS MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL STATINS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL STATINS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL STATINS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL STATINS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL STATINS MARKET SIZE, BY HOMECARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL STATINS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL STATINS MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS STATINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES STATINS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. CANADA STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 38. CANADA STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 39. CANADA STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 40. CANADA STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. CANADA STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. MEXICO STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 44. MEXICO STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 45. MEXICO STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. MEXICO STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA STATINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. UNITED KINGDOM STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED KINGDOM STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 65. UNITED KINGDOM STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 66. UNITED KINGDOM STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. UNITED KINGDOM STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. GERMANY STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. GERMANY STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 70. GERMANY STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 71. GERMANY STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. GERMANY STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. FRANCE STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. FRANCE STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 75. FRANCE STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 76. FRANCE STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. FRANCE STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. RUSSIA STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. ITALY STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. ITALY STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 85. ITALY STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 86. ITALY STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. ITALY STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. SPAIN STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. SPAIN STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 90. SPAIN STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 91. SPAIN STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. SPAIN STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. SAUDI ARABIA STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. SAUDI ARABIA STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 100. SAUDI ARABIA STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 101. SAUDI ARABIA STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. SAUDI ARABIA STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. SOUTH AFRICA STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. SOUTH AFRICA STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 105. SOUTH AFRICA STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 106. SOUTH AFRICA STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. SOUTH AFRICA STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. DENMARK STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. DENMARK STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 110. DENMARK STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 111. DENMARK STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. DENMARK STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. NETHERLANDS STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. NETHERLANDS STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. NETHERLANDS STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. QATAR STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. QATAR STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 120. QATAR STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 121. QATAR STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. QATAR STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. FINLAND STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. FINLAND STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 125. FINLAND STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 126. FINLAND STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. FINLAND STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. NIGERIA STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. EGYPT STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. EGYPT STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 140. EGYPT STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 141. EGYPT STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. EGYPT STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. TURKEY STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. TURKEY STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 145. TURKEY STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 146. TURKEY STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. TURKEY STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. ISRAEL STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. ISRAEL STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 150. ISRAEL STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. NORWAY STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. NORWAY STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 155. NORWAY STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 156. NORWAY STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. NORWAY STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. POLAND STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. POLAND STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 160. POLAND STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 161. POLAND STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. POLAND STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. SWITZERLAND STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. SWITZERLAND STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 165. SWITZERLAND STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 166. SWITZERLAND STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. SWITZERLAND STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC STATINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 174. CHINA STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. CHINA STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 176. CHINA STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 177. CHINA STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. CHINA STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. INDIA STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. INDIA STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 181. INDIA STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 182. INDIA STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. INDIA STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. JAPAN STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. JAPAN STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 186. JAPAN STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 187. JAPAN STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. JAPAN STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. THAILAND STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. THAILAND STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 206. THAILAND STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 207. THAILAND STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. THAILAND STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. SINGAPORE STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN STATINS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN STATINS MARKET SIZE, BY BRANDED, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN STATINS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN STATINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN STATINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. STATINS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 235. STATINS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Statins market report include:
  • Pfizer Inc.
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Viatris Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Limited
  • Apotex Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 35.35 Billion
Forecasted Market Value ( USD ) by 2030 $ 47.11 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Statin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Statin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Statins - Global Strategic Business Report - Product Image

Statins - Global Strategic Business Report

  • Report
  • 192 Pages
  • Global
From
Statin Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Statin Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 77 Pages
  • Global
From
Statin Market 2025-2029 - Product Image

Statin Market 2025-2029

  • Report
  • 210 Pages
  • Global
From
2024 Global Forecast for Statin Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Statin Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From

About the Statin Market

The Statin market is a subset of the Cardiovascular Drugs market, which includes medications used to treat and prevent heart disease. Statins are a type of drug used to lower cholesterol levels in the blood, reducing the risk of heart attack and stroke. They work by blocking an enzyme in the liver that is responsible for producing cholesterol. Statins are typically prescribed to people with high cholesterol levels, as well as those with a history of heart disease. Statin drugs are available in both generic and brand-name forms. Common brand-name statins include Lipitor, Crestor, and Zocor. Generic statins are also available, such as atorvastatin, rosuvastatin, and simvastatin. In addition to statins, other cardiovascular drugs include antihypertensives, anticoagulants, and antiarrhythmics. These drugs are used to treat and prevent a variety of heart-related conditions, such as high blood pressure, stroke, and arrhythmia. Some of the major companies in the Statin market include Pfizer, AstraZeneca, Merck, and Novartis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.